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Background: Vascular calcification is one of the common complications in diabetes mellitus. Many studies have
shown that high glucose (HG) caused cardiovascular calcification, but its underlying mechanism is not fully
understood. Recently, medial calcification has been most commonly described in the vessels of patients with
diabetes. Chondrocytes were involved in the medial calcification. Recent studies have shown that the conversion
into mesenchymal stem cells (MSCs) via the endothelial-to-mesenchymal transition (EndMT) could be triggered in
chondrocytes. Our previous research has indicated that HG induced EndMT in human aortic endothelial cells
(HAECs). Therefore, we addressed the question of whether HG-induced EndMT could be transitioned into MSCs and
differentiated into chondrocytes.
Methods: HAECs were divided into three groups: a normal glucose (NG) group, HG group (30 mmol/L), and
mannitol (5.5 mmol/L NG+ 24.5 mmol/L) group. Pathological changes were investigated using fluorescence
microscopy and electron microscopy. Immunofluorescence staining was performed to detect the co-expression of
endothelial markers, such as CD31, and fibroblast markers, such as fibroblast-specific protein 1 (FSP-1). The
expression of FSP-1 was detected by real time-PCR and western blots. Endothelial-derived MSCs were grown in
MSC medium for one week. The expression of the MSCs markers STRO-1, CD44, CD10 and the chondrocyte marker
SOX9 was detected by immunofluorescence staining and western blots. Chondrocyte expression was detected by
alcian blue staining. Calcium deposits were analyzed by alizarin red staining.
Results: The incubation of HAECs exposed to HG resulted in a fibroblast-like phenotype. Double staining of the
HAECs indicated a co-localization of CD31 and FSP-1. The expression of FSP-1 was significantly increased in the HG
group, and the cells undergoing EndMT also expressed STRO-1, CD44 and SOX9 compared with the controls
(P< 0.05). Additionally, alcian blue staining in the HG group was positive compared to the NG group. Consistent
with the evaluation of SOX9 expression, calcium deposits analyzed by alizarin red staining were also enhanced by
the HG treatment. Specifically, we showed that HG-induced EndMT is accompanied by the activation of the
canonical Snail pathway.
Conclusions: Our study demonstrated that HG could induce endothelial cells transdifferentiation into
chondrocyte-like cells via the EndMT, which is mediated in part by the activation of the Snail signaling pathway.
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Cardiovascular complications are the leading cause of
death in patients with diabetes mellitus (DM) [1]. Emer-
ging evidence suggests that the presence of vascular cal-
cification in any arterial wall in patients with DM is
associated with a 3-4-fold higher risk for mortality and
cardiovascular events [2]. Pathological studies have
shown that patients with DM exhibit characteristic calci-
fication in the tunica media, which is independently
associated with cardiovascular mortality [3]. However,
the pathogenesis of medial artery calcification (MAC) is
complex and has not been fully elucidated.
Traditionally, a calcium-phosphorus homeostasis im-
balance is considered the cause of calcium salt depos-
ition, which may play an important role in vascular
calcification by transforming vascular smooth muscle
cells (SMCs) to osteoblast-like cells, producing a matrix
of bone collagen and non-collagenous proteins. MAC
has recently been considered an orchestrated process
that begins with mesenchymal condensation, followed by
chondrogenesis and endochondral ossification [4,5].
However, the mechanisms responsible for these proce-
sses in diabetic vascular calcification remain largely
unknown.
In the past decade, SMCs and pericytes have been
reported to possess the plasticity to express bone and
cartilage proteins in calcified blood vessels [6,7]. How-
ever, recent studies have indicated that mature endothe-
lial cells can transform into fibroblasts in vitro and in
DM [8-11], by a process known as the endothelial-
mesenchymal transition (EndMT). Furthermore, Medici
et al. found that vascular endothelial cells have the po-
tential to convert into mesenchymal cells that possess
mesenchymal stem cells (MSCs) properties and are able
to differentiate into chondrocytes [12]. In addition,
chondrocyte conversion underlies medial calcification in
uremic rats [13]. Thus, whether EndMT might be a
novel source of chondrocytes during the MAC process
in patients with DM is an interesting question.A
Figure 1 Immunofluorescence staining of HAECs with CD31 in the NG
(30 mmol/L) for 48 h resulted in a fibroblast-like phenotype (B). 1 bar = 50Chronic high glucose (HG) is a major initiator of dia-
betic vascular complications and implicated in the devel-
opment of vascular calcification [14,15]. Our previous
studies have shown that 30 mmol/L HG induced human
aortic endothelial damage via the mediation of EndMT
and that EndMT contributed to cardiac fibrosis in dia-
betic rats, which was inhibited by irbesartan [16,17].
However, the relationship between HG-induced EndMT
and its association with chondrocyte transformation dur-
ing diabetic vascular calcification are still poorly under-
stood. In this study, we addressed the question of
whether HG-induced EndMT could be used to transition
human aortic endothelial cells (HAECs) into MSCs and
then differentiate into chondrocytes.
Materials and methods
Cell culture
Primary HAECs were purchased from Sciencell Research
Laboratories (USA) and cultured as previously described
[16]. Briefly, cells were grown in endothelial culture
medium (No. 1001, Sciencell) containing 5% fetal bovine
serum (FBS) (No. 0025), 1% endothelial cell growth sup-
plement (No. 1052) and 1% penicillin/streptomycin solu-
tion (No. 0503) in 5% CO2 at 37°C. Passage 2–5 HAECs
were expanded in monolayers in flasks or dishes. At ap-
proximately 80% confluence, the culture medium was
changed to a serum-free solution for 24 h prior to their
use in all experiments. And the HAECs were treated
with normal glucose (NG; 5.5 mmol/L), HG (30 mmol/L
D-glucose) [16], or 5.5 mmol/L NG+24.5 mmol/L man-
nitol for 48 h.
Cell differentiation
The cells were grown in chondrogenic differentiation
medium (MCDM, Sciencell) supplemented with TGF-β3
(Peprotech, Rocky Hill, USA) at a concentration of
10 ng/ml, followed by growth in serum-free medium
with HG at 30 mmol/L for 48 h. Alcian blue (Sigma)
staining for chondrogenic proteoglycans and alizarin redB
and HG groups. Note: The incubation of HAECs with high glucose













































Figure 2 (See legend on next page.)
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Figure 2 RT-PCR and western blot expression of CD31 in the NG and HG groups. Notes: The mRNA and protein expression of CD31 were
decreased in cells incubated with high glucose, whereas the expression of FSP-1 was increased. * P< 0.05 vs. control; # P< 0.05 vs. mannitol.
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cultures grown in chondrogenic medium for 7 days.
Real-time PCR
The total RNA from the cultured HAECs was extracted
using RNAiso Plus according to the manufacturer’s proto-
col (TAKARA, China). The RNA concentration and pur-
ity were confirmed with a Nanodrop 2000 (Thermo,
USA). Samples with a relative absorbance ratio between
1.8 and 2.0 at 260/280 were used. All RNA samples were
reverse transcribed (Applied Biosystems, USA).
The quantification of specific mRNAs was conducted
using an ABI Prism 7300 Sequence Detection System
(Applied Biosystems, USA) with the SYBR Green
Real-time PCR Kit (TAKARA, China). The following
oligonucleotide primer sequences were used: CD31,
forward 50-GAGTCCAGCCGCATATCC-30 and reverse
50-TGACACAATCGTATCTTCCTTC-30; FSP1, forward
50- GTCCACCTTCCACAAGTAC-30 and reverse 50 TG
TCCAAGTTGCTCATCAG-3; CD44, forward 50-GAG
CAGCACTTCAGGAGGTTAC-30 and reverse 50-GGAA
TGTGTCTTGGTCTCTGGTAG-30; CD10, forward 50-C
CTCGTTGACTGGTGGACTC-30 and reverse 50-CTG
ATAGGCTCTGTATGCTTGAC-30; SOX9, forward 50-G
CTCTGGAGACTTCTGAAC-30 and reverse 50-CGTT
CTTCACCGACTTCC-30; and β-actin, forward 50-CTGG
AAGGTGGACAGCGAGG-30 and reverse 50-TGACGTG
GACATCCGCAAAG-30. All primers were designed and
synthesized by Generay (Shanghai). The relative amount
of mRNA was normalized to β-actin and calculated using
the standard curve method. In brief, the pre-PCR prod-
uct of each gene was used as the standard. The standardA
Figure 3 The confocal microscopy analysis. Notes: Labeling experiment
fibroblast marker FSP1 (red). Confocal microscopy revealed that some cells
stage of EndMT. A: normal glucose. B: high glucose.curve was established with a 10-fold serial dilution of the
product and was included in all PCR runs. The ratio of
target gene abundance to housekeeping gene abundance
was used to evaluate the expression level of each gene.
Controls consisting of ddH2O were negative in all runs.
Western blot analysis
The total cellular protein was extracted to evaluate the
levels of CD31, FSP1, α-SMA, CD44, STRO-1 and
CD10. Equal amounts of cell lysate proteins (30 μg) were
separated on 4-20% SDS-polyacrylamide gels and trans-
ferred onto nitrocellulose membranes (Pall, USA) by
electroblotting. The blots were incubated overnight with
primary antibodies at concentrations recommended by
the respective manufacturers: CD31 (sc-65260, Santa
Cruz), FSP1 (ab27957, Abcam), CD44 (sc-71220, Santa
Cruz), and CD10 (sc-9149, Santa Cruz). A horse-radish
peroxidase-labeled secondary IgG (Santa Cruz, Europe)
was then added to the blots. The signals were detected
using an ECL advance system (GE Healthcare, UK).
β-actin was used as the internal control.
Immunofluorescence
HAECs grown on coverslips were fixed in 4% parafor-
maldehyde and permeabilized with 0.3% Trition-X100.
After blocking with 10% BSA for 1 h, they were incu-
bated with primary antibodies at 4°C overnight. The cells
were then incubated with AlexaFluor-conjugated sec-
ondary antibodies (Invitrogen Technology, USA) at
room temperature in the dark for 1 h. The absence of
primary antibody was used as a negative control. The
cells were visualized and photographed with a scanningB
s used antibodies against CD31 (endothelial cell marker; green) and the
acquired FSP1 staining and lost CD31 staining, which suggested the
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Germany; TCS SP5, Leica, Germany).
Electron microscopy
Ultra-thin cells were counter-stained with uranyl acetate
and lead citrate and were examined with a transmission
electron microscope (TEM, HITACHI H600). Dried
samples were sputtered with gold for observation by a
scanning electron microscope (SEM-505, Phillips, the
Netherlands).
Statistical analysis
The data were expressed as the means ± standard devi-
ation (SD). A one-way analysis of variance (ANOVA)
was performed and confirmed with a two-tailed paired
Student’s t test using SPSS 19.0. P values less than 0.5
were considered significant.
Results
HG induces EndMT in HAECs
As our previous experiment showed, we found that
HAECs treated with 30 mmol/L HG for 48 h induced
profound changes, with the cells becoming elongated,
spindle-shaped and losing cobblestone morphology under
fluorescence microscopy (Figure 1). The protein and
mRNA expressions of endothelial marker CD31 were
decreased in the cells incubated with HG, whereas theA
C 
Control
Figure 4 Cellular ultrastructure following HG treatment. Notes: TEM an
high glucose (30 mmol/L) exposure. The normal HAECs present with few m
exposure to HG, microfilamentation and a swollen rough endoplasmic retic
spindle-shaped (C, D). 1 bar = 4 μm.protein expression of FSP-1 was increased (Figure 2). Im-
munofluorescence with antibodies for the endothelial
marker and the mesenchymal marker demonstrated
that the HG-treated cells acquired FSP1 staining and
lost CD31 staining compared with the control cells
(Figure 3).
We next observed the cells under TEM and SEM.
HAECs treated with 30 mmol/L HG for 48 h showed a
distinct change from a cobblestone-like to a spindle-
shaped morphology. In addition, TEM was performed to
examine the ultrastructure of cells, which displayed nor-
mal structures. In contrast, the HG group treated for
48 h exhibited endothelial protrusion, a significantly
roughened endoplasmic reticulum, and microfilamenta-
tion (Figure 4). These data suggested that EndMT was
induced by the HG treatment.
HG-induced EndMT expresses mesenchymal stem markers
and acquires chondrocyte differentiation potential
To determine whether EndMT could cause an acquisi-
tion of MSCs-like phenotype, HAECs were treated with
HG to examine the expression of the MSC markers
CD44, CD10 and STRO-1. We performed immunofluor-
escence with antibodies for the MSC markers CD44 and
STRO-1. After incubation with 30 mmol/L HG for 48 h,
the cells showed significantly increased expression of
CD44 and STRO-1 compared with the control underB
D
High glucose
d SEM depicting the change in the cellular ultrastructure following
icrofilaments and a rough endoplasmic reticulum (A, B). After
ulum appeared in the cytoplasm, and the cells became elongated and
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control group, the HG treatment induced significantly
increased mRNA expression in CD44 and CD10 at
48 h post-treatment (Figure 6). In addition, the CD44
and CD10 protein expression was markedly increased
(Figure 7).
Because MSCs are multipotent, we next assessed the
chondrocyte differentiation capability of endothelial cells
that underwent EndMT. We exposed the ECs to the
30 mmol/L HG for 48 h after the cells were grown in
chondrogenic culture media for one week. Western blot
analysis showed that the expression of the chondrocyte-
specific marker SOX9 was significantly increased com-
pared with the control (Figure 8). Meanwhile, the HG-
treated HAECs stained positively for cartilage proteogly-
can alcian blue after growth in chondrogenic medium
for 7 days (Figure 9). Consistent with the evaluation of
SOX9 expression, calcium deposits as shown by alizarin
red staining were also enhanced by HG treatment
(Figure 9).Figure 5 Immunofluorescence staining of HAECs with CD44 and STRO
immunofluorescence staining of CD44 and STRO-1 (green) with DAPI. 1 baHG-induced EndMT is associated with the activation of
the Snail signaling pathway
To determine whether the EndMT triggered by HG
observed in our experiments was accompanied by the
activation of Snail, a western blot was performed using
HAECs treated with or without HG. The protein level of
Snail was significantly increased by treatment with HG
compared with the control (Figure 10).
Discussion
Vascular calcification is more common in patients with
diabetes compared with the general population and is
associated with increased mortality, stroke and amputa-
tions [1-3]. In addition, under HG conditions with
increased TNF-alpha levels, the death receptors TNF-R1
and Fas, are up-regulated in human coronary artery
endothelial cells, which could in turn play a role in HG-
induced endothelial cell apoptosis and hyperglycemia
appears to be a risk factor for vascular calcification
[14-16]. Many studies have shown that HG may cause-1 in the NG and HG groups. Note: Representative
r = 50 μm. Control: normal glucose. HG: high glucose.
Figure 6 RT-PCR expression of CD10 and CD44 in the NG and HG groups. Notes: HAECs were treated with 30 mmol/L high glucose for the
indicated times. The expression of MSCs markers (CD44, CD10) was detected by real-time PCR. The values represent the means ± SD. *, P< 0.05
vs. control.
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of plasma Matrix GLA protein indicates the progressing
calcification process in patients with type 2 DM [17],
but its underlying mechanism is not fully understood in
HG-induced endothelial injury. We repeated the same
results as a previous study: it showed that the treatment
of HAECs with HG led to a significantly increased ex-
pression of the FSP1 protein in a dose- and time-
dependent manner (data not shown). Double staining of
the HAECs showed co-localization of CD31 and FSP1,
the acquisition of a spindle-shaped morphology by some
cells and loss of CD31 staining, which indicated the oc-
currence of EndMT [18,19]. Furthermore, in this study,
the cells undergoing EndMT showed expression of
STRO-1, CD44 and SOX9 compared with the controls.
Additionally, alcian blue staining in the HG group was
positive compared with the NG group. The EndMT
resulted in the acquisition of MSCs-like properties to
enable the differentiation into chondrocytes, which is in
accordance with the report from Medici and colleagues
[12]. We first found that the HG-induced EndMT could
trigger the conversion into chondrocytes, which are
involved in the vascular medial calcification.
Chondrogenesis is a key pathologic mechanism under-
lying medial calcification [4,13]. Given its central role, it
is not surprising that the origins of ectopically accumu-
lated chondrocytes in the arterial wall have become an
attractive field in research. During the past decade,
the notion that SMCs undergo differentiation intochondrogenic cells to participate in MAC has already
gained acceptance [5,7]. However, conventional distinc-
tions among vascular cell lineages are becoming less
clear as our studies and other investigators determine
that ECs could also trans-differentiate into SMCs, a
process known as EndMT [10,11,18,19]. Furthermore,
studies found that EndMT has the ability to convert cells
into MSCs and then differentiate into chondrocytes [12].
MSCs are known to be multipotent cells with cartil-
age-, adipose-, and bone-forming potential that are wide-
spread in calcified lesions [20-23]. Previous studies have
determined that MSCs in adult humans and rodents are
derived from bone marrow, cord blood, placenta and
adipose tissue [21,23]. Recently, vascular endothelial
cells have been proposed to be one precursor of MSCs
in certain microenvironments [21,24]. TGF-β2 treat-
ment-induced EndMT contributes to the acquisition of
the MSC phenotype in ECs [12,23]. Kissa et al. [25] indi-
cated that ECs from the aortic ventral wall can trans-
formation into hematopoietic cells in animals. Slukvin
et al. [24] showed the MSCs could derive from EndMT.
More interestingly, Medici et al. found that chondrocytes
at the sites of heterotopic ossification stain positively
with antibodies specific for endothelial markers in pro-
gressive models of fibrodysplasia ossificans [12]. In our
experiment, we found that elevated HG could induce
the significantly increased expression of CD44, CD10,
and STRO-1 (markers of MSCs) and SOX9 (a transcrip-




Figure 7 Western blot expression of CD44 and CD10 in the NG and HG groups. Notes: HAECs were treated with or without 30 mmol/L HG
for 48 h. MSCs marker (CD44, CD10) expressions were detected by western blot. β-actin was used as internal control. Values represent the means ± SD.
*P<0.05 vs. control. #P<0.05 vs. mannitol.
Figure 8 Western blot expression of SOX9 in the NG and HG groups. Notes: Western blot analysis for the chondrocyte marker is shown
(SOX9). β-actin was used as an internal control. The values represent the means ± SD. *, P< 0.05 vs. control.





Figure 9 HAECs incubated with HG exhibit chondrocyte differentiation potency. Notes: HAECs were treated with or without 30 mM HG for
48 h followed by exposure to chondrogenic culture medium for 7 days (A). Alcian blue staining for cells grown in chondrogenic culture medium
for 7 days is shown (B, ×100). (C). Alizarin Red staining for calcium deposition (D, ×200).
Tang et al. Cardiovascular Diabetology 2012, 11:113 Page 9 of 11
http://www.cardiab.com/content/11/1/113cells undergoing EndMT. Meanwhile, HG-treated
HAECs stained positively for cartilage proteoglycan
alcian blue after growth in chondrogenic medium for
7 days. Consistent with the evaluation of SOX9 expres-
sion, calcium deposits as shown by alizarin red staining
were also enhanced by HG treatment. All of theseFigure 10 Western blot expression of Snail in the NG and HG groups
followed by exposure to chondrogenic culture medium for 7 days. The we
control. The values represent the means ± SD. *, P< 0.05 vs. control.experiments suggested that the endothelium may con-
tribute to chondrocyte genesis by MSCs generation,
which was involved in the diabetic vascular medial
calcification.
Recent work has shown that the exposure of ECs
to HG activates several signal transduction networks. Notes: HAECs were treated with 30 mmol/L high glucose for 48 h
stern blot analysis for Snail is shown. β-actin was used as an internal
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promoting responses. Snail has been implicated in a
wide variety of cellular responses, including transi-
tion, growth, gene expression, angiogenesis, contractility
and vesicle trafficking. Kokudo et al. [26] found that
Snail is required for the TGF ß-induced EndMT of
embryonic stem cell-derived ECs. Moreover, TGF-β2
promotes Snail-mediated endothelial-mesenchymal tran-
sition through the convergence of Smad-dependent and
Smad-independent signaling [27]. In addition, a role of
the TGF-β in the regulation of terminal chondrocyte dif-
ferentiation was recently reported [28]. Jayachandran
and colleagues [29] found that Snail transcription factors
mediate the epithelial-mesenchymal transition (EMT) in
lung fibrosis. EndMT is known to be a form of EMT
that is present during the embryonic development of the
heart [30], and glycogen synthase kinase-3 is an en-
dogenous inhibitor of Snail transcription, which has been
implicated in EMT [31]. Thus, we addressed the ques-
tion of whether Snail mediated the HG-induced EndMT.
Our results indicated that the protein level of Snail was
significantly increased by the HG treatment compared
with the control. Therefore, all of these findings support
the hypothesis that the effect of HG on EC transdifferen-
tiation into chondrocyte-like cells is mediated, at least in
part, through the Snail signaling pathway.Conclusions
Our study demonstrated that HG could induce endothe-
lial cells transdifferentiation into chondrocyte-like cells
via EndMT, which is mediated in part by the activa-
tion of the snail signaling pathway. Understanding the
mechanisms that control endothelium transdifferentia-
tion to osteochondroprogenitors and the subsequent
vascular calcification may help develop novel strategies
that prevent or reverse vascular calcification.
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